Embark on a fulfilling pharmacy career with our Pharmacy Technician Training Program. Our 16-week program allows you to gain the skills required for safe patient care. The self-paced format ensures ...
User-defined instructions (UDIs) let engineers write logic once and reuse it across many components, eliminating tedious copy-paste duplication. Any updates to a UDI definition automatically propagate ...
International Business Machines stock is getting slammed Monday, becoming the latest perceived victim of rapidly developing AI technology, after Anthropic said its Claude Code tool could be used to ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in Science Advances detailing the company's CRISPR-based Cellgorithm technology, ...
KYOTO, Japan--(BUSINESS WIRE)--OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage (“SF 2nd Stage”),” covering from FY2026 to FY2030, on November 7, 2025 (JST).
Recently, a friend asked me a question that's been floating around every boardroom and business school: "With AI writing code, does programming still matter?" It's a fair question. Generative AI can ...
Machine builders today face increasing complexity: almost every project becomes a custom design, with shorter lead times, tighter budgets, and growing demands for connectivity and flexibility. OMRON’s ...
Central Bank Digital Currencies (CBDCs) are more than just a digital version of cash; they represent a fundamental shift in how monetary policy, payments, and economic inclusion are imagined. At the ...
A team of Chinese researchers led by Prof. GAO Caixia from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences has developed two new genome editing technologies, ...
Noelle Acheson outlines the key blockchain innovations for payment programmability, and highlights their advantages and their risks. By redistributing creativity and responsibility, blockchains can ...
Omron is undervalued by 31%, presenting a strong buy opportunity due to excessive market pessimism and resilient fundamentals in automation and healthcare. The company boasts leading positions in ...